Ana holds a PhD in immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. Ana was awarded two FCT fellowships and has won the Portuguese Immunology Society Best Paper and Best Poster award in 2009 and 2010, as well as the CESPU International Research Award in 2010. After leaving the lab to pursue a career in science communication, she served as the director of science communication at iMM Lisbon.
Articles by Ana de Barros
Recent Posts
- CAR T-cell therapy Carvykti OK’d as second-line RRMM treatment
- Abecma OK’d in US to take earlier in treatments for multiple myeloma
- Steroid-free Venclexta combo shows promise in myeloma cells
- Abecma cleared in EU as earlier therapy for hard-to-treat myeloma
- CAR T-cell therapy recommended as earlier treatment line for RRMM